PURCHASE OPPORTUNITY Sample Clauses

PURCHASE OPPORTUNITY. If for any reason the CITY decides to remove and sell the sculpture, the CITY shall provide the SCULPTOR with the first opportunity to purchase the piece at reasonable market value, not to exceed its offering price to the market at large, prior to offering the sculpture to the market at large.
Sample 1Sample 2Sample 3See All (8)
PURCHASE OPPORTUNITY. (a) For the avoidance of doubt, the Participant shall be under no obligation to procure the purchase of Approved Vaccine as a result of entry into this Agreement. (b) Following receipt by Xxxx of the Upfront Payment: (i) Gavi will notify the Participant in writing, from time to time, of any opportunities to purchase Approved Vaccines from a Specified Manufacturer (the “Purchase Opportunity”); (ii) each Purchase Opportunity will set out the key terms of procurement and delivery of Approved Vaccines from the relevant Specified Manufacturer. The Participant acknowledges that the terms provided in the Purchase Opportunity may not be negotiated and will be binding on the Participant should it participate in a Purchase Opportunity; (iii) if the Participant does not wish to participate in a Purchase Opportunity the Participant shall notify Gavi in writing substantially in the form of Schedule 2 (Form of Non- Participation Notice) within the period specified by Xxxx in the notification of a Purchase Opportunity (such notice, a “Non-Participation Notice”); (iv) if the Participant does not deliver a Non-Participation Notice to Gavi, within the period specified by Gavi in the notification of the Purchase Opportunity, Gavi may, from time to time, notify the Participant of each Specified Manufacturers’ option to procure Approved Vaccines (a “Purchase Option”); and (v) on exercise of a Purchase Option from a Specified Manufacturer, the Participant shall: (A) procure from the relevant Specified Manufacturer, in accordance with Clause 4.1, its Pro Rata Share of the relevant Approved Vaccine (less any Prepaid Doses) (the “Assigned Doses”); and (B) take delivery of its Prepaid Doses it is entitled to receive from the relevant Specified Manufacturer, in each case as made available by the relevant Specified Manufacturer.
Sample 1
PURCHASE OPPORTUNITY. Subject to the terms and conditions herein, during the term of this Agreement as set forth in Section 4 (the "Term"), RxBazaar shall notify SCP of opportunities (a "Purchase Opportunity") for the purchase of pharmaceutical and medical products, as well as other related products (the "Spot Merchandise"), from third parties that RxBazaar would accept for resale. For each Purchase Opportunity, the notice from RxBazaar shall specify the type, the amount, the price, the payment date, the acceptance date and any other relevant terms for the purchase of the Spot Merchandise. On or before the acceptance date, SCP shall notify RxBazaar whether SCP accepts (including setting forth the expected repayment terms for the purchase) or rejects the Purchase Opportunity of the offered Spot Merchandise. In the event that SCP fails to respond to RxBazaar's notice by the acceptance date for such purchase, it shall be deemed that SCP rejected the Purchase Opportunity.
Sample 1

Related to PURCHASE OPPORTUNITY

  • Representatives Purchase Option The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date an option to purchase up to an aggregate of 600,000 units (the “Representative’s Units”) for an aggregate purchase price of $100.00, pursuant to a Purchase Option in substantially the form filed as an exhibit to the Registration Statement (the “Representative’s Purchase Option”). On the Closing Date, the Company shall deliver to the Representative, upon payment therefor, certificates for the Representative’s Purchase Option in the name or names and in such denominations as the Representative may request. The Representative’s Purchase Option, the Representative’s Units, the Shares (the “Representative’s Shares”) and the Warrants (the “Representative’s Warrants”) included in the Representative’s Units and the Shares issuable upon exercise of the Representative’s Warrants are hereinafter referred to collectively as the “Representative’s Securities.” The Public Securities and the Representative’s Securities are hereinafter referred to collectively as the “Securities.” Delivery and payment for the Representative’s Purchase Option shall be made on the Closing Date.

  • Post-IPO Warrants The Post-IPO Warrants, when and if issued, shall have the same terms and be in the same form as the Public Warrants except as may be agreed upon by the Company.

  • Purchase Options Neither the Property nor any part thereof are subject to any purchase options, rights of first refusal, rights of first offer or other similar rights in favor of third parties.

  • Notice to Warrant Holders Any notice required or permitted to be given to the Holders will be in writing and may be given by prepaid registered post, electronic facsimile transmission or other means of electronic communication capable of producing a printed copy to the address of the Holder appearing on the Holder’s Warrant or to such other address as any Holder may specify by notice in writing to the Company, and any such notice will be deemed to have been given and received by the Holder to whom it was addressed if mailed, on the third day following the mailing thereof, if by facsimile or other electronic communication, on successful transmission, or, if delivered, on delivery; but if at the time or mailing or between the time of mailing and the third business day thereafter there is a strike, lockout, or other labour disturbance affecting postal service, then the notice will not be effectively given until actually delivered.

  • New Securities “New Securities” shall mean any Common Stock or Preferred Stock of the Company, whether now authorized or not, and rights, options or warrants to purchase such Common Stock or Preferred Stock, and securities of any type whatsoever that are, or may become, convertible or exchangeable into such Common Stock or Preferred Stock; provided, however, that the term “New Securities” does not include:

  • Purchase or Sale of Partnership Securities The General Partner may cause the Partnership to purchase or otherwise acquire Partnership Securities; provided that, except as permitted pursuant to Section 4.10, the General Partner may not cause any Group Member to purchase Subordinated Units during the Subordination Period. As long as Partnership Securities are held by any Group Member, such Partnership Securities shall not be considered Outstanding for any purpose, except as otherwise provided herein. The General Partner or any Affiliate of the General Partner may also purchase or otherwise acquire and sell or otherwise dispose of Partnership Securities for its own account, subject to the provisions of Articles IV and X.

  • Reasonableness of Restrictions 2.4.1 Employee has carefully read and considered the provisions of Article 2 hereof and, having done so, agrees that the restrictions set forth in such Article (including, but not limited to, the time period of restriction and the geographical areas of restriction set forth in Article 2 hereof) are fair and reasonable and are reasonably required for the protection of the interest of Company, its officers, directors and other employees. 2.4.2 In the event that, notwithstanding the foregoing, any of the provisions of Article 2 hereof shall be held to be invalid or unenforceable, the remaining provisions thereof shall nevertheless continue to be valid and enforceable as though the invalid or unenforceable parts had not been included therein. In the event that any provision of Article 2 relating to time period and/or areas of restriction shall be declared by a court of competent jurisdiction to exceed the maximum time period or areas such court deems reasonable and enforceable, said time period and/or areas of restriction shall be deemed to become and thereafter be the maximum time period and/or areas which such court deems reasonable and enforceable.

  • Notice to Warrantholders In case the Company shall (a) effect any dividend or distribution described in Section 3.4(b), (b) effect any Reorganization Event, (c) make any distribution on or in respect of the Common Stock in connection with the dissolution, liquidation or winding up of the Company, or (d) reduce the then current Warrant Price pursuant to Section 3.4(d), then the Company shall mail to each holder of Warrants at such holder’s address as it shall appear on the books of the Warrant Agent, at least ten days prior to the applicable date hereinafter specified, a notice stating (x) the record date for such dividend or distribution, or, if a record is not to be taken, the date as of which the holders of record of Common Stock that will be entitled to such dividend or distribution are to be determined, (y) the date on which such Reorganization Event, dissolution, liquidation or winding up is expected to become effective, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such Reorganization Event, dissolution, liquidation or winding up, or (z) the first date on which the then current Warrant Price shall be reduced pursuant to Section 3.4(d). No failure to mail such notice nor any defect therein or in the mailing thereof shall affect any such transaction or any adjustment in the Warrant Price required by Section 3.4.

  • Warrant Holder Not Shareholder Except as otherwise provided herein, this Warrant does not confer upon the Holder any right to vote or to consent to or receive notice as a shareholder of the Company, as such, in respect of any matters whatsoever, or any other rights or liabilities as a shareholder, prior to the exercise hereof.

  • Purchase Option The Company hereby agrees to issue and sell to the Representative (and/or their designees) on the Effective Date an option ("Representative's Purchase Option") for the purchase of an aggregate of ______ units ("Representative's Units") for an aggregate purchase price of $100. Each of the Representative's Units is identical to the Firm Units except that the Warrants included in the Representative's Units ("Representative's Warrants") have an exercise price of $____ (___% of the exercise price of the Warrants included in the Units sold to the public). The Representative's Purchase Option shall be exercisable, in whole or in part, commencing on the later of the consummation of a Business Combination and one year from the Effective Date and expiring on the five-year anniversary of the Effective Date at an initial exercise price per Representative's Unit of $___, which is equal to _________ (___%) of the initial public offering price of a Unit. The Representative's Purchase Option, the Representative's Units, the Representative's Warrants and the shares of Common Stock issuable upon exercise of the Representative's Warrants are hereinafter referred to collectively as the "Representative's Securities." The Public Securities and the Representative's Securities are hereinafter referred to collectively as the "Securities." The Representative understands and agrees that there are significant restrictions against transferring the Representative's Purchase Option during the first year after the Effective Date, as set forth in Section 3 of the Representative's Purchase Option.